Shionogi & Co. Ltd (SGIOF PINK) stock market data APIs
$21.3876
0(0%)
as of February 4, 2026
Try our APIs with
free plan!
Shionogi & Co. Ltd Financial Data Overview
Price chart is built with
Anychart
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.
Prev. Close
21.3876
Open
21.3876
High
21.3876
Low
21.3876
52 wk Range
12.0585-23.17
Market Cap
21 769 M
P/E Ratio
16.5814
Shares Outstanding
851 M
Revenue
465 384 M
EPS
0.5695
Dividends (Yield)
0.5155
Beta
-0.024
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shionogi & Co. Ltd data using free add-ons & libraries
Get Shionogi & Co. Ltd Fundamental Data
Shionogi & Co. Ltd Fundamental data includes:
- Net Revenue: 465 384 M
- EBITDA: 199 035 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-01-30
- EPS/Forecast: 44.31
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shionogi & Co. Ltd News
New
Why Shionogi (TSE:4507) Is Up 6.2% After Profit Growth Outpaced Sales In Latest Results – And What's Next
Shionogi & Co., Ltd. reported earnings for the nine months ended December 31, 2025, with sales rising to ¥360,684 million and net income reaching ¥158,225 million, both higher than the same period a...
All You Need to Know About Shionogi & Co. (SGIOY) Rating Upgrade to Buy
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
SGIOY vs. ZTS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS). But which of these two stocks presents inve...
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks.Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership Reuters reported on January 20 that Britain’s ...
Get Shionogi & Co. Ltd fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
